Eton Pharmaceuticals Inc reports results for the quarter ended in June - Earnings Summary

Eton Pharmaceuticals

08/08/2024 22:51

* Eton Pharmaceuticals Inc  ETON.OQ  reported a quarterly
adjusted
loss of 12 cents​​ per share for the quarter ended in June,
lower than the same quarter last year, when the company reported
EPS of 15 cents.  The mean expectation of two analysts for the
quarter was for a loss of 7 cents per share. 
    * Revenue fell 24.4% to $9.07 million from a year ago;
analysts
expected $8.80 million. 
    * Eton Pharmaceuticals Inc's reported EPS for the quarter
was a
loss of 12 cents​.
    * The company reported a quarterly loss of $3.04 million.
    * Eton Pharmaceuticals Inc shares had risen by 6.1% this
quarter and lost 20.3% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 380%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the
pharmaceuticals
peer group is also "buy"

Wall Street's median 12-month price target for Eton
Pharmaceuticals Inc is $8.00 
This summary was machine generated from LSEG data August 8 at
09:51 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jan. 1 0001       -0.07          -0.12          Missed
 Mar. 31 2024      -0.04          -0.03          Beat
 Dec. 31 2023      -0.04          -0.09          Missed
 Sep. 30 2023      -0.10          -0.02          Beat